Loading...
Cancer and Thrombosis: New Treatments, New Challenges
The direct-acting oral anticoagulant (DOAC) has become an alternative to low-molecular-weight heparin (LMWH) for treatment and prophylaxis of venous thromboembolism (VTE) in cancer patients. The clinicians are, however, faced with difficult decisions regarding DOAC treatment: Which patients cannot u...
Na minha lista:
| Udgivet i: | Med Sci (Basel) |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8293316/ https://ncbi.nlm.nih.gov/pubmed/34204957 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medsci9020041 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|